NCT06979687

Brief Summary

Caesarean section (CS) is an increasingly common mode of delivery. The way in which this operation is carried out is important as it affects millions of women each. In recent years use of a 'self-retaining' suture or thread for closure of the uterine closure has become a recognised approach with a proven safety record. These sutures are known as knotless barbed sutures (KBS) as the unidirectional barbs on the surface of the suture hold the suture in the tissue without the need for knots. These sutures can be used instead of the usual 'smooth' suture which requires knots at the angles. There are high-level level data that CS are quicker and on average need fewer additional stitches to control blood loss when KBS are used. There is additional evidence of a potential reduction in problems with healing of the uterus with KBS, it is thought that this might lead to a lower risk of problems in repeat CS as the chance of the placenta implanting into the scar might be lower. At present this evidence is based on ultrasound surveillance of scar appearance which is an indirect measure. The real risk difference will need to be explored with the examination of real world outcomes over the coming years. There is currently no published data on KBS for uterine closure at caesarean from the UK. This cohort, although retrospective, is adequately controlled, shows excellent outcomes and signals a potential marked reduction in infectious morbidity. This potentially means a better patient experience as well as a large cost saving because of reduced re-admission rates. These data were collected as part of a service improvement project but the generalisable nature of our findings mean the finding are research and should be published.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
957

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 20, 2025

Completed
Last Updated

May 29, 2025

Status Verified

January 1, 2025

Enrollment Period

2.3 years

First QC Date

May 13, 2025

Last Update Submit

May 22, 2025

Conditions

Keywords

Knotless barbed suturecaesarean sectioncaesarean deliverycaesarean birth

Outcome Measures

Primary Outcomes (1)

  • Post-operative infection

    Whether antibiotics were prescribed for a surgical site infective complication.

    up to 6 weeks post-operative

Secondary Outcomes (4)

  • operating time

    Intraoperative

  • Blood loss

    In theatre during the operation

  • Readmission

    up to 6 weeks post-operative

  • Re-attendance as an outpatient

    up to 6 weeks post-operative

Other Outcomes (1)

  • Operative complications

    Intraoperative and up to 6 weeks post-operatively

Study Arms (6)

Group 1 (Elective Caesareans undertaken using knotless barbed suture)

Elective caesareans undertaken using knotless barbed sutures. This included all cases without exception on the CI's regular operating list from January 2023 (after a positive trial period which resulted in this becoming the standard for the CI). n290.

Procedure: knotless barbed suture closure of the hysterotomy at caesarean section

Group 2 (Elective caesarean sections on a number of consultant lists using standard sutures SS)

May-August 2024 all cases on the respective lists n215

Procedure: Standard 2 layer closure of caesarean hysterotomy using 910 polyglactin suture (SS)

Group 3 (Emergency caesarean deliveries when KBS was used for closure of the hysterotomy)

Emergency caesarean deliveries (category 1-3 urgency - all except elective) using KBS January 2023-December 2024. n 107.

Procedure: knotless barbed suture closure of the hysterotomy at caesarean section

Group 4 (Emergency caesarean deliveries employing Standard sutures for closure of the hysterotomy)

All non-cat 4 CS using SS (May-August 2024) n 345

Procedure: Standard 2 layer closure of caesarean hysterotomy using 910 polyglactin suture (SS)

Group 5 (comprising all cases in group 1 and group 3)

All the KBS caesarean deliveries n 397

Procedure: knotless barbed suture closure of the hysterotomy at caesarean section

Group 6 (comprising group 2 and group 4)

All the SS cases n560

Procedure: Standard 2 layer closure of caesarean hysterotomy using 910 polyglactin suture (SS)

Interventions

Use of Medtronic V-loc 180 suture (VL) for a 2 layer closure of the caesarean hysterotomy rather than the standard 2 layer closure using the 910 polyglactin suture (SS).

Group 1 (Elective Caesareans undertaken using knotless barbed suture)Group 3 (Emergency caesarean deliveries when KBS was used for closure of the hysterotomy)Group 5 (comprising all cases in group 1 and group 3)

Standard 2 layer closure using the 910 polyglactin suture (SS)

Group 2 (Elective caesarean sections on a number of consultant lists using standard sutures SS)Group 4 (Emergency caesarean deliveries employing Standard sutures for closure of the hysterotomy)Group 6 (comprising group 2 and group 4)

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women having a caesarean section at James Cook University Hospital within the study period

You may qualify if:

  • Women undergoing a caesarean section at the study hospital within the data collection period for that cohort - either with or without KBS depending on the cohort.

You may not qualify if:

  • Not falling within the search criteria for a comparator group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

James Cook University Hospital

Middlesbrough, TS43BW, United Kingdom

Location

MeSH Terms

Conditions

Infections

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2025

First Posted

May 20, 2025

Study Start

November 1, 2022

Primary Completion

February 11, 2025

Study Completion

February 11, 2025

Last Updated

May 29, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

IPD will be shared via CT.gov on an excel spreadsheet without identifiable information being provided

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Feb 2025
Access Criteria
Open access on CT.gov
More information

Locations